GlassScriptPhysician profile
Susan Guo
NPI 1932375805
$17,810.30
in general payments reported to CMS, 2019-2025
27 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $690 · 2020: $1,179 · 2021: $12K · 2022: $3,284 · 2023: $63.75 · 2024: $238 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $431 · Education: $19.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $430.89 |
| Education | $19.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $15,223.39 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $956.68 | 2020-2022 | |
| Regeneron Pharmaceuticals, INC. | $526.08 | 2019 | |
| Nxstage Medical, INC. | $222.17 | 2022-2024 | |
| Tempus Ai, INC | $134.17 | 2024-2025 | Xt Cdx |
| Merit Medical Systems INC | $82.82 | 2021 | |
| Elekta, INC. | $69.88 | 2019 | |
| Travere Therapeutics, INC. | $67.62 | 2022-2025 | |
| Janssen Biotech, INC. | $64.99 | 2021 | |
| Novocure INC. | $64.77 | 2022-2023 | Optune |
| Veloxis Pharmaceuticals, INC. | $60.67 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $43.50 | 2021 | |
| Sensus Healthcare, INC. | $37.71 | 2019 | |
| Q Biomed INC. | $29.19 | 2021 | |
| Seagen INC. | $26.22 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $21.62 | 2025 | |
| Puma Biotechnology, INC. | $19.56 | 2019 | |
| Palette Life Sciences, INC. | $19.36 | 2022 | |
| Novartis Pharmaceuticals Corporation | $19.31 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.57 | 2020 | |
| La Jolla Pharmaceutical Company | $17.39 | 2020 | |
| Myriad Genetic Laboratories, INC. | $16.90 | 2024 | Prolaris |
| Gilead Sciences, INC. | $15.37 | 2023 | Trodelvy |
| Chiesi USA, INC. | $14.38 | 2019 | |
| Alexion Pharmaceuticals, INC. | $12.88 | 2020 | |
| Boston Scientific Corporation | $12.65 | 2021 | |
| Karyopharm Therapeutics INC. | $12.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Guo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.